This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
Copyright © 2019 Med Learning Group. Built by Divigner. All Rights Reserved.
Smoking cessation is an important part of chronic obstructive pulmonary disease (COPD) management.1,2 In fact, among patients who continue to smoke (about 50% of patients diagnosed with COPD), smoking cessation is the most effective strategy to slow down disease progression and reduce mortality.3 Many tools are available to assist patients in quitting various types of tobacco products, which may include  cigars, cigarettes, e-cigarettes and vaping devices.2,3 They may consist of behavior interventions and/or pharmacotherapy, with combination therapy shown to be more effective than either intervention alone.3 Recidivism rates can be high, with up to 85% still smoking after one year.3,4 Second-line strategies for reducing harmful effects of COPD on progression can include a reduction in the amount of smoked cigarettes.4 Asking about tobacco use at every visit and assessing patient willingness to quit are vital clinical interventions in the pathway to smoking cessation.5 Please visit the additional resources page for more tools to help your patients quit smoking.
All URLS accessed 1/31/24.
This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
Copyright © 2019 Med Learning Group. Built by Divigner. All Rights Reserved.